Categories: News

The Assistance Fund Opens New Program for Narcolepsy

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Narcolepsy

ORLANDO, FLORIDA / ACCESSWIRE / January 9, 2025 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with narcolepsy. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.

Narcolepsy is a lifelong condition that causes people to feel sleepy or suddenly fall asleep. People living with narcolepsy struggle to stay awake for long periods of time, leading to significant impacts on their lives. While the cause of narcolepsy is not yet known, many people living with narcolepsy have a parent who also has the disease.1

“People living with narcolepsy face unique challenges, but accessing treatment shouldn’t be one of them,” said Danielle Vizcaino, President and CEO of The Assistance Fund. “Through TAF’s Narcolepsy Copay Assistance Program, we are committed to helping eligible individuals afford the treatment they need to manage their condition.”

“Managing the daily hurdles of narcolepsy while coping with the financial strain of treatment can be overwhelming for people living with this condition,” said Tammy Anderson, Executive Director of Wake Up Narcolepsy. “The Assistance Fund’s Narcolepsy Copay Assistance Program will be an invaluable resource, helping more patients access treatment that may improve their quality of life.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (844) 933-5106 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 100 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 210,000 children and adults access the treatment they need to stay healthy or manage a life-changing disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

1Mayo Clinic, “Narcolepsy,” https://www.mayoclinic.org/diseases-conditions/narcolepsy/symptoms-causes/syc-20375497, accessed December 2024.

Contact Information

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

SOURCE: The Assistance Fund

View the original press release on accesswire.com

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

3 hours ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

3 hours ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

3 hours ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

6 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

6 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

6 hours ago